Metabolic activation of aegeline mediated by CYP2C19

References

• Avula, B., et al., 2016. Simultaneous determination of aegeline and six coumarins from different parts of the plant Aegle marmelos using UHPLC-PDA-MS and chiral separation of aegeline enantiomers using HPLC-ToF-MS. Planta medica, 82 (5), 580–588.
   PubMed Web of Science ®Google Scholar
• Cartus, A.T., and Schrenk, D., 2020. Metabolism of carcinogenic alpha-asarone by human cytochrome P450 enzymes. Naunyn-Schmiedeberg's archives of pharmacology, 393 (2), 213–223.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2019. Identification of quinone methide intermediate resulting from metabolic activation of icaritin in vitro and in vivo. Chemical research in toxicology, 32, 969–973.
   PubMed Web of Science ®Google Scholar
• Cortez, N.A., et al., 2013. Synthesis of (R)-tembamide and (R)-aegeline via asymmetric transfer hydrogenation in water. Tetrahedron: asymmetry, 24 (20), 1297–1302.
   Google Scholar
• Derf, A., et al., 2019. Aegeline, a natural product from the plant Aegle marmelos, mimics the yeast SNARE protein Sec22p in suppressing α-synuclein and Bax toxicity in yeast. Bioorganic and medicinal chemistry letters, 29 (3), 454–460.
   PubMed Web of Science ®Google Scholar
• Gautam, S., et al., 2015. Aegeline from Aegle marmelos stimulates glucose transport via Akt and Rac1 signaling, and contributes to a cytoskeletal rearrangement through PI3K/Rac1. European journal of pharmacology, 762, 419–429.
   PubMed Web of Science ®Google Scholar
• Ha-Duong, N.T., et al., 2001. Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19. Biochemistry, 40 (40), 12112–12122.
   PubMed Web of Science ®Google Scholar
• Heidemann, L.A., et al., 2016. Severe acute hepatocellular injury attributed to OxyELITE Pro: a case series. Digestive diseases and sciences, 61 (9), 2741–2748.
   PubMed Web of Science ®Google Scholar
• Horiyama, S., et al., 2016. Intracellular metabolism of α,β-unsaturated carbonyl compounds, acrolein, crotonaldehyde and methyl vinyl ketone, active toxicants in cigarette smoke: participation of glutathione conjugation ability and aldehyde-ketone sensitive reductase activity. Chemical & pharmaceutical bulletin, 64 (6), 585–593.
   PubMed Web of Science ®Google Scholar
• Jaeschke, H., McGill, M.R., and Ramachandran, A., 2012. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug metabolism reviews, 44 (1), 88–106.
   PubMed Web of Science ®Google Scholar
• Leung, L., Kalgutkar, A.S., and Obach, R.S., 2012. Metabolic activation in drug-induced liver injury. Drug metabolism reviews, 44 (1), 18–33.
   PubMed Web of Science ®Google Scholar
• Li, H., Peng, Y., and Zheng, J., 2020. Dioscorea bulbifera L.-induced hepatotoxicity and involvement of metabolic activation of furanoterpenoids. Drug metabolism reviews, 52 (4), 568–584.
   PubMed Web of Science ®Google Scholar
• Lin, D., et al., 2014. Cytochrome P450-mediated metabolic activation of diosbulbin B. Drug metabolism and disposition, 42 (10), 1727–1736.
   PubMed Web of Science ®Google Scholar
• Maity, P., et al., 2009. Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.) Corr. Indian journal of experimental biology, 47, 849–861.
   PubMed Web of Science ®Google Scholar
• Manda, V.K., et al., 2016. Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents. Xenobiotica, 46 (2), 117–125.
   PubMed Web of Science ®Google Scholar
• Manda, V.K., et al., 2019. Pharmacokinetics and tissue distribution of aegeline after oral administration in mice. Planta medica, 85 (06), 491–495.
   PubMed Web of Science ®Google Scholar
• Mäurer, M., et al., 1992. Stereoelectronic and steric effects in the synthesis and recognition of diastereomeric ethers by NMR and EPR spectroscopy. Chemische berichte, 125 (4), 857–865.
   Google Scholar
• Minet, E.F., et al., 2012. A comparative in vitro kinetic study of [14C]-eugenol and [14C]-methyleugenol activation and detoxification in human, mouse, and rat liver and lung fractions. Xenobiotica, 42 (5), 429–441.
   PubMed Web of Science ®Google Scholar
• Mohammed, M.M.D., et al., 2016. Two new cytotoxic furoquinoline alkaloids isolated from Aegle marmelos (Linn.) Correa. Natural product research, 30 (22), 2559–2566.
   PubMed Web of Science ®Google Scholar
• Norman, B.H., 2020. Drug induced liver injury (DILI). Mechanisms and medicinal chemistry avoidance/mitigation strategies. Journal of medicinal chemistry, 63 (20), 11397–11419.
   PubMed Web of Science ®Google Scholar
• Nugroho, A.E., et al., 2011. Effects of aegeline, a main alkaloid of Aegle marmelos Correa leaves, on the histamine release from mast cells. Pakistan journal of pharmaceutical sciences, 24, 359–367.
   PubMed Web of Science ®Google Scholar
• Parkinson, A., et al., 2011. An evaluation of the dilution method for identifying metabolism-dependent inhibitors of cytochrome P450 enzymes. Drug metabolism and disposition, 39 (8), 1370–1387.
   PubMed Web of Science ®Google Scholar
• Qu, Y., Yang, J., and Chen, S., 2015. Synthesis of octopamine derivatives and investigation of their antioxidation activities. Chinese journal of marine drugs, 31, 37–40.
   Google Scholar
• Raheja, S., et al., 2019. Aegle marmelos leaf extract ameliorates the cognitive impairment and oxidative stress induced by intracerebroventricular streptozotocin in male rats. Life sciences, 221, 196–203.
   PubMed Web of Science ®Google Scholar
• Rodrigues, A.D., 1999. Integrated cytochrome P450 reaction phenotyping: attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes. Biochemical pharmacology, 57, 465–480.
   PubMed Web of Science ®Google Scholar
• Ronis, M.J.J., Pedersen, K.B., and Watt, J., 2018. Adverse effects of nutraceuticals and dietary supplements. Annual review of pharmacology and toxicology, 58 (1), 583–601.
   PubMed Web of Science ®Google Scholar
• Sahi, J., et al., 2010. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery. Current drug discovery technologies, 7 (3), 188–198.
   PubMedGoogle Scholar
• Shen, L., et al., 2012. Isolation and primary culture of rat hepatic cells. Journal of visualized experiments, 64, 3917.
   Google Scholar
• Shi, Q., Greenhaw, J., and Salminen, W.F., 2014. Inhibition of cytochrome P450s enhances (+)-usnic acid cytotoxicity in primary cultured rat hepatocytes. Journal of applied toxicology, 34 (8), 835–840.
   PubMed Web of Science ®Google Scholar
• Silva, E.M.P., and Silva, A.M.S., 2012. Cheminform abstract: 1,6-conjugate addition of nucleophiles to α,β,γ,δ-diunsaturated systems. Synthesis, 44 (20), 3109–3128.
   Web of Science ®Google Scholar
• Singh, A., et al., 2019. LOX-1, the common therapeutic target in hypercholesterolemia: a new perspective of antiatherosclerotic action of aegeline. Oxidative medicine and cellular longevity, 2019, 1–11.
   Web of Science ®Google Scholar
• VandenBrink, B.M., and Isoherranen, N., 2010. The role of metabolites in predicting drug-drug interactions: focus on irreversible cytochrome P450 inhibition. Current opinion in drug discovery & development, 13, 66–77.
   PubMed Web of Science ®Google Scholar
• Zhang, L., et al., 2020. Cytochrome P450 3A4-mediated bioactivation and its role in nomilin-induced hepatotoxicity. Chemical research in toxicology, 33 (8), 2208–2217.
   PubMed Web of Science ®Google Scholar
• Zhou, H., et al., 2020. Cytochrome P450-mediated bioactivation: implication for the liver injury induced by fraxinellone, a bioactive constituent from Dictamni cortex. Chemical research in toxicology, 33 (7), 1960–1968.
   PubMed Web of Science ®Google Scholar